Filing Details
- Accession Number:
- 0001628280-24-002454
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-29 16:40:50
- Reporting Period:
- 2024-01-25
- Accepted Time:
- 2024-01-29 16:40:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 785786 | Plexus Corp | PLXS | Printed Circuit Boards (3672) | 391344447 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1607273 | John Patrick Jermain | One Plexus Way Neenah WI 54956 | Exec. Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Acquisiton | 2024-01-25 | 8,280 | $0.00 | 61,135 | No | 4 | M | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2024-01-25 | 3,952 | $94.46 | 57,183 | No | 4 | F | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2024-01-29 | 2,532 | $92.51 | 54,651 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Restricted Stock Units | Disposition | 2024-01-25 | 8,280 | $0.00 | 8,280 | $0.00 |
| Common Stock, $.01 Par Value | Restricted Stock Units | Acquisiton | 2024-01-29 | 9,630 | $0.00 | 9,630 | $0.00 |
| Common Stock, $.01 Par Value | Performance Stock Units | Acquisiton | 2024-01-29 | 9,050 | $0.00 | 9,050 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 9,630 | No | 4 | A | Direct | ||
| 9,050 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $.01 Par Value | 3,426 | Indirect | 401(k) |
Footnotes
- Shares of Plexus Corp. common stock held in the Plexus Corp. 401(k) Retirement Plan as of the last report from the Plan's trustee.
- Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 25, 2024.
- This transaction was executed in multiple trades at prices ranging from $92.10 to $92.935 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 29, 2027.
- Each Performance Stock Unit ("PSU") granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock if certain conditions are satisfied. Vesting of 4,230 PSUs is dependent on the relative total shareholder return ("TSR") of Plexus Corp.'s common stock as compared to companies in the S&P 400 Index and vesting of the remainder is based on goals related to economic return ("ER") during the three-year performance period. The target number of PSUs that may be earned is reported above. The reporting person may earn up to 150% of the targeted amount that is based on TSR and up to 200% of the targeted amount that is based on ER.
Billionaire Hedge Funds
